Aelis Farma S.A.
AELIS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €1 | €1 | €4 | €5 |
| % Growth | -37.8% | -65.1% | -22.5% | – |
| Cost of Goods Sold | €0 | €3 | €0 | €0 |
| Gross Profit | €1 | €1 | €4 | €7 |
| % Margin | 100% | 100% | 100% | 125.1% |
| R&D Expenses | €4 | €5 | €6 | €9 |
| G&A Expenses | €1 | €2 | €2 | €2 |
| SG&A Expenses | €1 | €2 | €2 | €2 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€0 | -€1 | -€0 | €0 |
| Operating Expenses | €5 | €6 | €8 | €11 |
| Operating Income | -€4 | -€4 | -€4 | -€5 |
| % Margin | -463.1% | -283% | -88.9% | -100.7% |
| Other Income/Exp. Net | -€0 | €5 | -€5 | €1 |
| Pre-Tax Income | -€4 | €1 | -€9 | -€4 |
| Tax Expense | €0 | €0 | -€5 | -€1 |
| Net Income | -€4 | -€4 | -€4 | -€3 |
| % Margin | -483% | -269.3% | -86.9% | -64.8% |
| EPS | -0.32 | -0.28 | -0.27 | -0.26 |
| % Growth | -14.3% | -3.7% | -3.8% | – |
| EPS Diluted | -0.32 | -0.28 | -0.27 | -0.26 |
| Weighted Avg Shares Out | 14 | 14 | 13 | 13 |
| Weighted Avg Shares Out Dil | 14 | 14 | 13 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | -€1 | €0 | €0 |
| EBITDA | -€4 | -€4 | -€4 | -€4 |
| % Margin | -458.5% | -310% | -85.8% | -74.5% |